These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20058701)

  • 1. [Rheb-mTOR signaling pathway involved in tumor formation].
    Sato T; Nakashima A; Tamanoi F
    Tanpakushitsu Kakusan Koso; 2010 Jan; 55(1):11-7. PubMed ID: 20058701
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the Rheb-mTOR signaling pathway in mammalian cells: constitutive active mutants of Rheb and mTOR.
    Sato T; Umetsu A; Tamanoi F
    Methods Enzymol; 2008; 438():307-20. PubMed ID: 18413257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid regulation of TOR complex 1.
    Avruch J; Long X; Ortiz-Vega S; Rapley J; Papageorgiou A; Dai N
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E592-602. PubMed ID: 18765678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events.
    Nardella C; Chen Z; Salmena L; Carracedo A; Alimonti A; Egia A; Carver B; Gerald W; Cordon-Cardo C; Pandolfi PP
    Genes Dev; 2008 Aug; 22(16):2172-7. PubMed ID: 18708577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
    Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
    J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of protein synthesis by amino acids in muscle of neonates.
    Suryawan A; Davis TA
    Front Biosci (Landmark Ed); 2011 Jan; 16(4):1445-60. PubMed ID: 21196241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
    Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
    J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis.
    Lu ZH; Shvartsman MB; Lee AY; Shao JM; Murray MM; Kladney RD; Fan D; Krajewski S; Chiang GG; Mills GB; Arbeit JM
    Cancer Res; 2010 Apr; 70(8):3287-98. PubMed ID: 20388784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenic activity and therapeutic inhibition of Rheb GTPase.
    Mavrakis KJ; Zhu H; Silva RL; Mills JR; Teruya-Feldstein J; Lowe SW; Tam W; Pelletier J; Wendel HG
    Genes Dev; 2008 Aug; 22(16):2178-88. PubMed ID: 18708578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras homolog enriched in brain (Rheb) enhances apoptotic signaling.
    Karassek S; Berghaus C; Schwarten M; Goemans CG; Ohse N; Kock G; Jockers K; Neumann S; Gottfried S; Herrmann C; Heumann R; Stoll R
    J Biol Chem; 2010 Oct; 285(44):33979-91. PubMed ID: 20685651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.
    Bai X; Ma D; Liu A; Shen X; Wang QJ; Liu Y; Jiang Y
    Science; 2007 Nov; 318(5852):977-80. PubMed ID: 17991864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin induces VSMC differentiation through inhibition of Rheb and mTOR.
    Wagner RJ; Martin KA; Powell RJ; Rzucidlo EM
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C119-27. PubMed ID: 20375271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively active Rheb induces oncogenic transformation.
    Jiang H; Vogt PK
    Oncogene; 2008 Sep; 27(43):5729-40. PubMed ID: 18521078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.
    Sancak Y; Bar-Peled L; Zoncu R; Markhard AL; Nada S; Sabatini DM
    Cell; 2010 Apr; 141(2):290-303. PubMed ID: 20381137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rheb switch 2 segment is critical for signaling to target of rapamycin complex 1.
    Long X; Lin Y; Ortiz-Vega S; Busch S; Avruch J
    J Biol Chem; 2007 Jun; 282(25):18542-18551. PubMed ID: 17470430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb.
    Lee MN; Ha SH; Kim J; Koh A; Lee CS; Kim JH; Jeon H; Kim DH; Suh PG; Ryu SH
    Mol Cell Biol; 2009 Jul; 29(14):3991-4001. PubMed ID: 19451232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR in podocyte function: is rapamycin good for diabetic nephropathy?
    Lu MK; Gong XG; Guan KL
    Cell Cycle; 2011 Oct; 10(20):3415-6. PubMed ID: 22067710
    [No Abstract]   [Full Text] [Related]  

  • 18. The switch I region of Rheb is critical for its interaction with FKBP38.
    Ma D; Bai X; Guo S; Jiang Y
    J Biol Chem; 2008 Sep; 283(38):25963-70. PubMed ID: 18658153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheb signaling and tumorigenesis: mTORC1 and new horizons.
    Armijo ME; Campos T; Fuentes-Villalobos F; Palma ME; Pincheira R; Castro AF
    Int J Cancer; 2016 Apr; 138(8):1815-23. PubMed ID: 26234902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of autophagy in cardioprotection.
    Sciarretta S; Yee D; Shenoy V; Nagarajan N; Sadoshima J
    High Blood Press Cardiovasc Prev; 2014 Mar; 21(1):21-8. PubMed ID: 24235024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.